|
Delayed
BURSA MALAYSIA
04:50:01 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.6850 MYR | -0.72% |
|
+2.24% | -0.72% |
| Market Cap | 152M 37.13M 33.05M 30.63M 27.76M 52.17M 3.52B 53.04M 368M 144M 1.84B 139M 136M 5.87B | P/E 2026 * |
9.73x | P/E 2027 * | 9.21x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 37.13M 33.05M 30.63M 27.76M 52.17M 3.52B 53.04M 368M 144M 1.84B 139M 136M 5.87B | EV / Sales 2026 * |
0.62x | EV / Sales 2027 * | 0.57x |
| Free-Float |
15.96% | Yield 2026 * |
3.65% | Yield 2027 * | 3.94% |
| 1 day | -0.72% | ||
| 1 week | +2.24% | ||
| Current month | +2.24% | ||
| 1 month | +1.48% | ||
| 3 months | -2.14% | ||
| 6 months | +0.74% | ||
| Current year | -0.72% |
| 1 week | 0.67 |  | 0.68 |
| 1 month | 0.67 | | 0.69 |
| Current year | 0.62 | | 0.72 |
| 1 year | 0.62 | | 0.72 |
| 3 years | 0.58 | | 0.8 |
| 5 years | 0.58 | | 0.8 |
| 10 years | 0.57 | | 1.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ban Keong Lim
CEO | Chief Executive Officer | 55 | 2015-03-31 |
Yan San Chan
DFI | Director of Finance/CFO | 56 | 2013-12-31 |
| Chief Operating Officer | 38 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 77 | 2015-03-31 | |
Ban Keong Lim
BRD | Director/Board Member | 55 | 2015-03-31 |
Kam Weng Foong
BRD | Director/Board Member | 66 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/31/25 | Buy | Chief Executive Officer | 110,000 | 0.0497% | ||
| 9/22/23 | Buy | Chief Executive Officer | 17,000 | 0.0077% | ||
| 9/8/23 | Buy | Chief Executive Officer | 103,000 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | +2.24% | 0.00% | +3.01% | 37.4M | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,106B | |
| +2.19% | +4.32% | +33.88% | +69.52% | 612B | |
| +2.26% | +5.37% | +24.57% | +97.69% | 500B | |
| +2.58% | +8.37% | +38.71% | +63.14% | 367B | |
| +3.25% | +4.45% | +71.80% | +44.44% | 354B | |
| +1.85% | +6.04% | +21.47% | +49.17% | 286B | |
| +1.76% | +6.07% | +0.43% | +20.98% | 256B | |
| +3.29% | +6.32% | +44.71% | +57.43% | 230B | |
| +2.25% | +5.81% | +27.13% | +101.17% | 190B | |
| Average | +1.77% | +3.77% | +32.14% | +62.61% | 390.02B | |
| Weighted average by Cap. | +1.43% | +4.67% | +40.82% | +80.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 244M 59.67M 53.11M 49.22M 44.61M 83.83M 5.65B 85.23M 591M 232M 2.96B 224M 219M 9.44B | 265M 64.99M 57.84M 53.61M 48.58M 91.3M 6.16B 92.83M 643M 253M 3.22B 244M 239M 10.28B |
| Net income | 15.6M 3.82M 3.4M 3.15M 2.86M 5.37M 362M 5.46M 37.83M 14.86M 189M 14.33M 14.04M 604M | 15.6M 3.82M 3.4M 3.15M 2.86M 5.37M 362M 5.46M 37.83M 14.86M 189M 14.33M 14.04M 604M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | MYR 0.6850 | -0.72% | 31,800 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 5278 Stock
Select your edition
All financial news and data tailored to specific country editions
